BioDlink International Company Limited (1875.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.63B
Enterprise Value1.68B
P/E Ratio-14.5
PEG Ratio0.03
Price/Sales Ratio4.61
Price/Book Ratio3.76
Enterprise/Revenue4.78
Enterprise/EBITDA-58.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.32
Operating Margin-0.31
AD

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.26

Income Statement

Revenue747.65M
Revenue/Share0.69
Gross Profit388.98M
EBITDA-6.44M
Net Income-100.37M
Diluted EPS-0.14

Balance Sheet

Total Cash263.69M
Total Cash/Share0.36
Total Debt350.93M
Total Debt/Equity0.57
Current Ratio2.15
Book Value Per Share0.85

Price History

52-Week Change66.07
52-Week High5.87
52-Week Low1.7
Moving Average 50 Days3.73
Moving Average 200 Days3.93

Statistics

Average Volume570,256
Shares Outstanding725.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD